Codes / ICD10CM / N02.7

N02.7 Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Recurrent and Persistent Hematuria with Diffuse Crescentic Glomerulonephritis
  • ICD-10 Code: N02.7

Summary

Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis is a severe kidney condition characterized by repeated or ongoing blood in the urine, associated with widespread inflammation and crescent formation in the kidney's filtering structures (glomeruli). This condition often indicates significant glomerular damage and requires prompt evaluation and management to address underlying causes and prevent progression.

Causes

The condition typically arises from immune-mediated processes, such as autoimmune diseases or infections, that trigger severe inflammation in the glomeruli. Common triggers include systemic vasculitis, anti-glomerular basement membrane disease, or post-infectious glomerulonephritis. The diffuse crescentic changes reflect extensive damage to the kidney's filtration units, often leading to rapid kidney dysfunction.

Risk Factors

  • Autoimmune Disorders: Conditions like systemic lupus erythematosus or granulomatosis with polyangiitis.
  • Infections: Recent or unresolved bacterial or viral infections that may trigger immune responses.
  • Genetic Predisposition: Family history of glomerular or autoimmune kidney diseases.
  • Environmental Exposures: Certain medications or toxins that may induce immune reactions.

Symptoms

  • Visible blood in the urine (hematuria), which may be persistent or recurrent.
  • Decreased urine output or oliguria.
  • Swelling (edema) in the legs, ankles, or face due to fluid retention.
  • Fatigue, nausea, or shortness of breath from kidney dysfunction.
  • High blood pressure (hypertension) in some cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Urinalysis confirms hematuria and may reveal protein or cellular casts. Blood tests assess kidney function (e.g., creatinine, BUN) and immune markers. A kidney biopsy is often performed to identify diffuse crescentic glomerulonephritis and rule out other causes. Imaging, such as ultrasound, may evaluate kidney size and structure.

Treatment Options

Treatment focuses on addressing the underlying cause and managing symptoms. Immunosuppressive therapies, such as corticosteroids or cytotoxic agents, are used to reduce inflammation. Plasmapheresis may be employed in severe cases, particularly with anti-glomerular basement membrane disease. Supportive care includes blood pressure control, diuretics for edema, and dialysis if kidney failure occurs. Close monitoring of kidney function is essential.

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and response to treatment. Diffuse crescentic glomerulonephritis can progress rapidly to kidney failure if untreated. Early intervention improves outcomes, but some patients may require long-term dialysis or kidney transplantation. Regular follow-up with nephrology is critical to monitor kidney function, adjust therapies, and manage complications.

Complications

  • Acute Kidney Injury: Rapid decline in kidney function requiring dialysis.
  • Chronic Kidney Disease: Long-term damage leading to permanent kidney impairment.
  • Hypertension: Persistent high blood pressure due to kidney dysfunction.
  • Infection Risk: Increased susceptibility from immunosuppressive treatments.

Lifestyle & Prevention

  • Manage Underlying Conditions: Control autoimmune diseases or infections promptly.
  • Avoid Nephrotoxic Substances: Limit use of medications or toxins that harm kidneys.
  • Monitor Blood Pressure: Maintain healthy levels to reduce kidney strain.
  • Stay Hydrated: Adequate fluid intake supports kidney function, unless contraindicated.

When to Seek Professional Help

Seek immediate medical attention if you experience:

  • Sudden or worsening blood in the urine.
  • Severe swelling, especially in the legs or face.
  • Reduced urine output or difficulty urinating.
  • Chest pain, shortness of breath, or confusion, which may indicate kidney failure.

Tips for Medical Coders

When coding N02.7, ensure documentation specifies "recurrent and persistent hematuria" with "diffuse crescentic glomerulonephritis" to align with the code's definition. Verify that the diagnosis is supported by clinical findings, such as biopsy results or imaging, and that the condition is not better described by another code. Accurate documentation of the underlying cause (e.g., autoimmune vs. infectious) may be relevant for additional coding or reporting.

Book a walkthrough

N02.7 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.